China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

The biotech sector has underperformed the overall market. Those are sentiments echoed by JPMorgan analyst Chris Schott, given ...

Verve Therapeutics stock jumped after a report said pharmaceutical giant Eli Lilly is in advanced talks to buy the ...

The global biotechnology sector is on track to become a multi-trillion dollar industry. Worldwide, the biotech space was ...

However, RBC Capital has reiterated that Vertex could require stronger execution to adopt Alyftrek to justify the current ...

In the volatile biotech industry, it is easy to overlook small-cap medical device companies, particularly those that are not ...

On the smaller end of the scale, ARK sold 13,154 shares of Adaptive Biotechnologies Corp (NASDAQ: ADPT) through its ARKG ETF, ...

China's biotechnology stocks have experienced a significant rally, outperforming AI, with a 60% surge since January due to ...

Biotech stock Verve Therapeutics Inc (NASDAQ:VERV) is up 75.3% to trade at $10.99 at last check amid news that peer Eli Lilly ...

The rally in the sector this year outpaces the 17% gain in China’s tech stocks that was driven by the release of DeepSeek’s ...

An analyst's downbeat new take on Summit Therapeutics ( SMMT -1.93%) pushed its stock downward on Hump Day. At the end of ...

Crinetics Pharmaceuticals trades at a steep discount while maintaining strong analyst support and a ~$3B valuation. Learn why ...